Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J MacFarlane

Showing results (771-780 of 806) with videos related to

Pageof 81
Sort By:
The Journal of Rheumatology|February 1, 2025
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration NetworkMarion Pons, Stylianos Georgiadis, Merete Lund Hetland, et al.
Arthritis Research & Therapy|October 20, 2023
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaborationLouise Linde, Lykke M Ørnbjerg, Simon H Rasmussen, et al.
Epidemiology (Cambridge, Mass.)|October 3, 2019
Laryngeal Cancer Risks in Workers Exposed to Lung Carcinogens: Exposure-Effect Analyses Using a Quantitative Job Exposure MatrixAmy L Hall, Hans Kromhout, Joachim Schüz, et al.
Rheumatology (Oxford, England)|June 14, 2023
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registriesLouise Linde, Lykke M Ørnbjerg, Stylianos Georgiadis, et al.
Rheumatology (Oxford, England)|October 31, 2019
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpACecilie Heegaard Brahe, Lykke Midtbøll Ørnbjerg, Lennart Jacobsson, et al.
Spine|January 1, 2008
A consensus approach toward the standardization of back pain definitions for use in prevalence studiesClermont E Dionne, Kate M Dunn, Peter R Croft, et al.
Investigative Ophthalmology & Visual Science|June 4, 2020
Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility LociXiu-Feng Huang, Zhixiu Li, Erika De Guzman, et al.
International Journal of Cancer|January 25, 2023
A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markersSanjeev Budhathoki, Brenda Diergaarde, Geoffrey Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2026
Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR studyDanni Cheng, Katrina Hueniken, Tianzhichao Hou, et al.
Seminars in Arthritis and Rheumatism|February 1, 2024
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practiceSara Nysom Christiansen, Simon Horskjær Rasmussen, Marion Pons, et al.
Pageof 81

Showing results (771-780 of 806) with videos related to

Sort By:
Pageof 81
The Journal of Rheumatology|February 1, 2025
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration NetworkMarion Pons, Stylianos Georgiadis, Merete Lund Hetland, et al.
Arthritis Research & Therapy|October 20, 2023
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaborationLouise Linde, Lykke M Ørnbjerg, Simon H Rasmussen, et al.
Epidemiology (Cambridge, Mass.)|October 3, 2019
Laryngeal Cancer Risks in Workers Exposed to Lung Carcinogens: Exposure-Effect Analyses Using a Quantitative Job Exposure MatrixAmy L Hall, Hans Kromhout, Joachim Schüz, et al.
Rheumatology (Oxford, England)|June 14, 2023
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registriesLouise Linde, Lykke M Ørnbjerg, Stylianos Georgiadis, et al.
Rheumatology (Oxford, England)|October 31, 2019
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpACecilie Heegaard Brahe, Lykke Midtbøll Ørnbjerg, Lennart Jacobsson, et al.
Spine|January 1, 2008
A consensus approach toward the standardization of back pain definitions for use in prevalence studiesClermont E Dionne, Kate M Dunn, Peter R Croft, et al.
Investigative Ophthalmology & Visual Science|June 4, 2020
Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility LociXiu-Feng Huang, Zhixiu Li, Erika De Guzman, et al.
International Journal of Cancer|January 25, 2023
A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markersSanjeev Budhathoki, Brenda Diergaarde, Geoffrey Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2026
Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR studyDanni Cheng, Katrina Hueniken, Tianzhichao Hou, et al.
Seminars in Arthritis and Rheumatism|February 1, 2024
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practiceSara Nysom Christiansen, Simon Horskjær Rasmussen, Marion Pons, et al.
Pageof 81